The deal range was $13.00-$14.00. Jefferies and Piper Sandler acted as joint book running managers for the offering.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRBP:
- Corbus Pharmaceuticals TBA Spot Secondary; price range $13.00-$14.00
- Corbus Pharmaceuticals Announces Preliminary Q3 Financials
- Corbus announces common stock and warrants offering, no amount given
- Corbus Pharmaceuticals price target raised to $39 from $32 at Mizuho
- Corbus Pharmaceuticals Advances CRB-701 Clinical Study for Solid Tumors